nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—corpus luteum—testicular cancer	0.713	0.713	CbGeAlD
Allylestrenol—ESR1—embryo—testicular cancer	0.059	0.059	CbGeAlD
Allylestrenol—PGR—female gonad—testicular cancer	0.0416	0.0416	CbGeAlD
Allylestrenol—ESR1—gonad—testicular cancer	0.04	0.04	CbGeAlD
Allylestrenol—PGR—testis—testicular cancer	0.0369	0.0369	CbGeAlD
Allylestrenol—ESR1—female gonad—testicular cancer	0.0325	0.0325	CbGeAlD
Allylestrenol—ESR1—testis—testicular cancer	0.0289	0.0289	CbGeAlD
Allylestrenol—PGR—lymph node—testicular cancer	0.0267	0.0267	CbGeAlD
Allylestrenol—ESR1—lymph node—testicular cancer	0.0209	0.0209	CbGeAlD
